We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Immunotherapy Approach Shrinks or Eliminates Advanced Tumors

By LabMedica International staff writers
Posted on 03 Nov 2016
Print article
Image: In this image, the top row shows few T-cells in untreated mice, while the bottom rows show many T-cells produced after immunotherapy treatment (Photo courtesy of Massachusetts Institute of Technology).
Image: In this image, the top row shows few T-cells in untreated mice, while the bottom rows show many T-cells produced after immunotherapy treatment (Photo courtesy of Massachusetts Institute of Technology).
A novel four-component approach to anti-cancer immunotherapy overcame the complex network of immunosuppressive pathways present in advanced tumors and caused shrinkage of several types of tumors in different mouse models.

Up to now attempts to treat tumors with immunotherapy have had only limited success probably due in part to the complex network of immunosuppressive pathways present in advanced tumors, which are unlikely to be overcome by intervention at a single signaling checkpoint.

To deal with these multiple pathways, investigators at the Massachusetts Institute of Technology (Cambridge, USA) developed a combination immunotherapy approach that recruited a variety of innate and adaptive immune cells. The treatment comprised four parts: an antibody targeted to the tumor, a vaccine targeted to the tumor; the cytokine interleukin-2 (IL-2), and a molecule that blocked the programmed cell death 1 (PD1) protein, a receptor found on T-cells. Each component had a critical role to perform. The antibodies stimulated the recruitment of additional immune cells that helped to activate T-cells; the vaccine stimulated proliferation of T- cells to attack the tumor; IL-2 prompted the T-cell population to expand quickly; and the anti-PD1 molecule extended T-cell activity.

The investigators tested this combination treatment in mice that had been implanted with three different types of tumors: melanoma, lymphoma, and breast cancer. They reported in the October 24, 2016, online edition of the journal Nature Medicine that about 75% of the well-established tumors in all strains of experimental mice were completely eliminated. Furthermore, six months later, the immune systems of these mice retained the ability to completely clear freshly injected tumor cells.

"We have shown that with the right combination of signals, the endogenous immune system can routinely overcome large immunosuppressive tumors, which was an unanswered question," said senior author Dr. Darrell Irvine, professor of biological engineering and of materials science and engineering at the Massachusetts Institute of Technology. "We had this really good lymph-node-targeting vaccine that will drive very strong adaptive immunity, and they had this combination that was recruiting innate immunity very efficiently. We wondered if we could bring these two together and try to generate a more integrated immune response that would bring together all arms of the immune system against the tumor."

Related Links:
Massachusetts Institute of Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.